Viewing Study NCT00076856


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
Study NCT ID: NCT00076856
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2004-02-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module